Prof. Asif Ahmed
profasif.bsky.social
Prof. Asif Ahmed
@profasif.bsky.social
Founder & CEO @MirZyme. Poet, #Vascular #scientist, father, husband & #entrepreneur. Founder of Aston Medical School. #health & #preeclampsia
MirZyme is pioneering a game-changing solution with one test, one pill—to save two lives.

✅ M-PREG® – A breakthrough digital #diagnostic that combines a simple blood test with AI-driven algorithms to predict #preeclampsia risk.

#Biotech
February 3, 2025 at 8:54 AM
Honoured to be invited as a keynote speaker at the 4th ACE Drug Discovery Summit in London! MirZyme is redefining precision medicine with our ‘rule-in’ digital diagnostics (M-PREG®️) and breakthrough oral therapeutics—a first-in-class approach directly tackling the root cause of preeclampsia.
January 30, 2025 at 9:12 PM
HARD TIMES CREATE ENTREPRENEURS & INNOVATORS.

ENTREPRENEURS & INNOVATORS CREATE GOOD TIMES.

GOOD TIMES CREATE PRIVILEGED PEOPLE.

PRIVILEGED PEOPLE CREATE HARD TIMES.
January 26, 2025 at 10:04 PM
Imagine a world where one test and one pill can save both mother and baby. At MirZyme, we’re making this a reality. #SteveJobs spoke about the rare chance to give back to society by creating something entirely new. His was a ‘bicycle for the mind’. At MirZyme, our focus is maternal health (M-PREG).
November 18, 2024 at 1:46 PM
Pregnancy is a risky business! MirZyme one test, one pill show potential for saving lives. MirZyme’s digital diagnostic platform, M-PREG®, has completed clinical trials and will gain market authorisation soon. Our oral drug, MZe786, is showing promising results in animal trials and PK studies.
November 15, 2024 at 11:27 PM
Our one test, one pill, save two lives. MirZyme’s digital diagnostic platform, M-PREG®, has completed clinical trials, while our drug MZe786 is showing promising results in animal trials. We aim to address market gaps, reduce healthcare costs, and alleviate societal burdens with these advancements.
November 15, 2024 at 11:23 PM